Who is sponsoring NCT05389566?

NCT05389566 is sponsored by Aalborg University Hospital.

What drugs are being tested in NCT05389566?

Interventions in NCT05389566: Quantative Sensory Testing, NCStat-DPN-Check, Composite Autonomic Symptom Score 31, Computerized dynamic posturography, Video Head Impulse Test, Accelerometer, Handgrip strength, Dual Energy X-ray Absorbtimetry scan, Force Plate Platform.

What condition does NCT05389566 study?

NCT05389566 studies Diabetic Peripheral Neuropathy, Diabetes, Balance; Distorted, Vestibular Neuropathy, Muscle Weakness, Sarcopenia, Autonomic Neuropathy, Diabetic, Small Fiber Neuropathy.

Is NCT05389566 still recruiting?

NCT05389566 is currently completed. Last updated 9 August 2024.

Last reviewed 2024-08-09 · How we verify

NCT05389566: DIAFALL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diabetes, Falls, and Fractures

Completed Last updated 9 August 2024

What this trial tests

trial testing Quantative Sensory Testing in Diabetic Peripheral Neuropathy in 110 participants. Completed in 1 September 2022.

Timeline

6 May 2022

Primary endpoint
20 May 2022

1 September 2022

Quick facts

Lead sponsor	Aalborg University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	110
Start date	6 May 2022
Primary completion	20 May 2022
Estimated completion	1 September 2022
Sites	1 location across Denmark

Drugs / interventions tested

Quantative Sensory Testing
NCStat-DPN-Check
Composite Autonomic Symptom Score 31
Computerized dynamic posturography
Video Head Impulse Test
Accelerometer
Handgrip strength
Dual Energy X-ray Absorbtimetry scan
Force Plate Platform

Conditions studied

Diabetic Peripheral Neuropathy — all drugs for Diabetic Peripheral Neuropathy →
Diabetes — all drugs for Diabetes →
Balance; Distorted — all drugs for Balance; Distorted →
Vestibular Neuropathy — all drugs for Vestibular Neuropathy →

Sponsor

Aalborg University Hospital

Who can join

Adults 40 to 70, any sex, with Diabetic Peripheral Neuropathy or Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparing severity of diabetic peripheral neuropathy (small and large fibers including autonomic neuroapthy) to postural control and vestibular measurements

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

The co-existence of peripheral and vestibular neuropathy in diabetes: a cross-sectional study.
Mahalingasivam AA, Jespersen AK, Ejskjaer N, Hougaard DD, et al · · 2024 · cited 7× · PMID 37515636 · DOI 10.1007/s00405-023-08130-6
Glial fibrillary acidic protein: a potential biomarker for small fiber neuropathy?
Hviid CVB, Rasmussen NH, Røikjer J. · · 2025 · cited 1× · PMID 40192786 · DOI 10.1007/s00592-025-02500-8
Profiling bone status indices reveals evidence of a low-turnover bone phenotype in type 2 diabetes: findings from the DiaFALL cohort.
Rasmussen NH, Kvist AV, Bech AA, Lykkeboe S, et al · · 2026 · PMID 41563408 · DOI 10.1007/s00198-026-07850-9

Verify or expand the search:

Other recruiting trials for Diabetic Peripheral Neuropathy

Currently open trials in the same condition.

NCT07380880 — Comparison of Proprioceptive Neuromuscular Training and Sensory Re-education in Patients With Diabetic Peripheral Neurop · NA · recruiting
NCT06591780 — Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy · NA · recruiting
NCT07036796 — Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy · Phase 2 · recruiting
NCT07085130 — The Effect of Hand and Foot Exercises Combined With Cold Application or Virtual Reality on Diabetic Neuropathy · NA · active not recruiting
NCT06483620 — Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire · recruiting

Other Aalborg University Hospital trials

Trials by the same sponsor.

NCT06960005 — ThyMoves: Screening and Exercise to Improve Muscle, Enhance Quality of Life, and Reduce Fall Risk in Thyroid Disease · NA · enrolling by invitation
NCT06745544 — Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes · NA · recruiting
NCT07185958 — Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy · not yet recruiting
NCT07165574 — Prevalence of Anticholinergics in Geriatric Patients With Acute Functional Deterioration · not yet recruiting
NCT07173413 — Assessing the Quality of Telephone Follow-Up After Spine Surgery · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05389566 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aalborg University Hospital
Last refreshed: 9 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05389566.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing